药物对比
Repaglinide vs Troglitazone
Repaglinide刺激胰岛素释放，Troglitazone改善胰岛素敏感性。Troglitazone因肝毒性已撤市，Repaglinide是现行选择。
此页面暂无可用的对比维度。
临床背景
Individuals with type 2 diabetes who are considering treatment options may compare Repaglinide and Troglitazone to understand their respective roles in blood glucose management.
结论
Repaglinide is the preferred current option compared to Troglitazone, which has been withdrawn due to safety concerns.
全部药物对比